An essential role for nuclear factor kappa B in preventing TNF-α-induced cell death in prostate cancer cells

Makoto Sumitomo, Masaaki Tachibana, Jun Nakashima, Masaru Murai, Akira Miyajima, Fumihiro Kimura, Masamichi Hayakawa, Hiroshi Nakamura

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Purpose: Although tumor necrosis factor-α (TNF-α) induces a strong cytotoxic effect on cell growth, many authors have reported that various cancer cells are resistant to TNF-α and the basis for this sensitivity or resistance to TNF-α remains to be elucidated. Since nuclear factor kappa B (NF-κB) activation has recently been reported to inhibit TNF-α-induced cell death, we studied whether NF-κB also assumes a protective role in TNF-α-induced cell death in prostate cancer cells. Materials and Methods: We used two human prostate cancer cell lines of DU145 and PC-3. We prepared two different NF-κB inhibitors, pyrrolidine dithiocarbamate (PDTC) and NF-κB decoy. NF-κB DNA binding activity was detected by electrophoretic mobility shift assay (EMSA). Cell survivals were measured by MTT assay. Induction of apoptosis was detected by nuclear staining and measured by fragmented DNA ELISA. Results: EMSA showed that NF-κB inhibitors continuously inhibited TNF-α-induced NF-κB activation. Cell growth was not inhibited by either TNF-α (50 ng./ml. or less) or NF-κB inhibitors. However, both PCA cells treated with TNF-α (20 ng./ml.) plus NF-κB inhibitors showed significant growth inhibition compared with controls (p <0.05). Nuclei of PCA cells appeared severely fragmented by this combination therapy. Furthermore, the levels of DNA fragmentation were significantly elevated in PCA cells treated with TNF-α (20 ng./ml.) plus NF-κB inhibitors compared with controls (p <0.05). Conclusions: NF-κB activation is suggested to produce the resistance of DU145 and PC-3 to TNF-α and that the combination of TNF-α and NF-κB inhibitors could be constituted an effective therapy to TNF-α-resistant human prostate cancer cells.

Original languageEnglish
Pages (from-to)674-679
Number of pages6
JournalJournal of Urology
Volume161
Issue number2
Publication statusPublished - 1999 Feb
Externally publishedYes

Fingerprint

NF-kappa B
Prostatic Neoplasms
Cell Death
Tumor Necrosis Factor-alpha
Passive Cutaneous Anaphylaxis
Electrophoretic Mobility Shift Assay
Growth
DNA
DNA Fragmentation
Cell Nucleus
Cell Survival
Enzyme-Linked Immunosorbent Assay
Apoptosis

Keywords

  • Apoptosis
  • NF-κB
  • Prostate cancer
  • TNF-α

ASJC Scopus subject areas

  • Urology

Cite this

Sumitomo, M., Tachibana, M., Nakashima, J., Murai, M., Miyajima, A., Kimura, F., ... Nakamura, H. (1999). An essential role for nuclear factor kappa B in preventing TNF-α-induced cell death in prostate cancer cells. Journal of Urology, 161(2), 674-679.

An essential role for nuclear factor kappa B in preventing TNF-α-induced cell death in prostate cancer cells. / Sumitomo, Makoto; Tachibana, Masaaki; Nakashima, Jun; Murai, Masaru; Miyajima, Akira; Kimura, Fumihiro; Hayakawa, Masamichi; Nakamura, Hiroshi.

In: Journal of Urology, Vol. 161, No. 2, 02.1999, p. 674-679.

Research output: Contribution to journalArticle

Sumitomo, M, Tachibana, M, Nakashima, J, Murai, M, Miyajima, A, Kimura, F, Hayakawa, M & Nakamura, H 1999, 'An essential role for nuclear factor kappa B in preventing TNF-α-induced cell death in prostate cancer cells', Journal of Urology, vol. 161, no. 2, pp. 674-679.
Sumitomo M, Tachibana M, Nakashima J, Murai M, Miyajima A, Kimura F et al. An essential role for nuclear factor kappa B in preventing TNF-α-induced cell death in prostate cancer cells. Journal of Urology. 1999 Feb;161(2):674-679.
Sumitomo, Makoto ; Tachibana, Masaaki ; Nakashima, Jun ; Murai, Masaru ; Miyajima, Akira ; Kimura, Fumihiro ; Hayakawa, Masamichi ; Nakamura, Hiroshi. / An essential role for nuclear factor kappa B in preventing TNF-α-induced cell death in prostate cancer cells. In: Journal of Urology. 1999 ; Vol. 161, No. 2. pp. 674-679.
@article{08398d0e324d43769357e5d5b67aa7f1,
title = "An essential role for nuclear factor kappa B in preventing TNF-α-induced cell death in prostate cancer cells",
abstract = "Purpose: Although tumor necrosis factor-α (TNF-α) induces a strong cytotoxic effect on cell growth, many authors have reported that various cancer cells are resistant to TNF-α and the basis for this sensitivity or resistance to TNF-α remains to be elucidated. Since nuclear factor kappa B (NF-κB) activation has recently been reported to inhibit TNF-α-induced cell death, we studied whether NF-κB also assumes a protective role in TNF-α-induced cell death in prostate cancer cells. Materials and Methods: We used two human prostate cancer cell lines of DU145 and PC-3. We prepared two different NF-κB inhibitors, pyrrolidine dithiocarbamate (PDTC) and NF-κB decoy. NF-κB DNA binding activity was detected by electrophoretic mobility shift assay (EMSA). Cell survivals were measured by MTT assay. Induction of apoptosis was detected by nuclear staining and measured by fragmented DNA ELISA. Results: EMSA showed that NF-κB inhibitors continuously inhibited TNF-α-induced NF-κB activation. Cell growth was not inhibited by either TNF-α (50 ng./ml. or less) or NF-κB inhibitors. However, both PCA cells treated with TNF-α (20 ng./ml.) plus NF-κB inhibitors showed significant growth inhibition compared with controls (p <0.05). Nuclei of PCA cells appeared severely fragmented by this combination therapy. Furthermore, the levels of DNA fragmentation were significantly elevated in PCA cells treated with TNF-α (20 ng./ml.) plus NF-κB inhibitors compared with controls (p <0.05). Conclusions: NF-κB activation is suggested to produce the resistance of DU145 and PC-3 to TNF-α and that the combination of TNF-α and NF-κB inhibitors could be constituted an effective therapy to TNF-α-resistant human prostate cancer cells.",
keywords = "Apoptosis, NF-κB, Prostate cancer, TNF-α",
author = "Makoto Sumitomo and Masaaki Tachibana and Jun Nakashima and Masaru Murai and Akira Miyajima and Fumihiro Kimura and Masamichi Hayakawa and Hiroshi Nakamura",
year = "1999",
month = "2",
language = "English",
volume = "161",
pages = "674--679",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - An essential role for nuclear factor kappa B in preventing TNF-α-induced cell death in prostate cancer cells

AU - Sumitomo, Makoto

AU - Tachibana, Masaaki

AU - Nakashima, Jun

AU - Murai, Masaru

AU - Miyajima, Akira

AU - Kimura, Fumihiro

AU - Hayakawa, Masamichi

AU - Nakamura, Hiroshi

PY - 1999/2

Y1 - 1999/2

N2 - Purpose: Although tumor necrosis factor-α (TNF-α) induces a strong cytotoxic effect on cell growth, many authors have reported that various cancer cells are resistant to TNF-α and the basis for this sensitivity or resistance to TNF-α remains to be elucidated. Since nuclear factor kappa B (NF-κB) activation has recently been reported to inhibit TNF-α-induced cell death, we studied whether NF-κB also assumes a protective role in TNF-α-induced cell death in prostate cancer cells. Materials and Methods: We used two human prostate cancer cell lines of DU145 and PC-3. We prepared two different NF-κB inhibitors, pyrrolidine dithiocarbamate (PDTC) and NF-κB decoy. NF-κB DNA binding activity was detected by electrophoretic mobility shift assay (EMSA). Cell survivals were measured by MTT assay. Induction of apoptosis was detected by nuclear staining and measured by fragmented DNA ELISA. Results: EMSA showed that NF-κB inhibitors continuously inhibited TNF-α-induced NF-κB activation. Cell growth was not inhibited by either TNF-α (50 ng./ml. or less) or NF-κB inhibitors. However, both PCA cells treated with TNF-α (20 ng./ml.) plus NF-κB inhibitors showed significant growth inhibition compared with controls (p <0.05). Nuclei of PCA cells appeared severely fragmented by this combination therapy. Furthermore, the levels of DNA fragmentation were significantly elevated in PCA cells treated with TNF-α (20 ng./ml.) plus NF-κB inhibitors compared with controls (p <0.05). Conclusions: NF-κB activation is suggested to produce the resistance of DU145 and PC-3 to TNF-α and that the combination of TNF-α and NF-κB inhibitors could be constituted an effective therapy to TNF-α-resistant human prostate cancer cells.

AB - Purpose: Although tumor necrosis factor-α (TNF-α) induces a strong cytotoxic effect on cell growth, many authors have reported that various cancer cells are resistant to TNF-α and the basis for this sensitivity or resistance to TNF-α remains to be elucidated. Since nuclear factor kappa B (NF-κB) activation has recently been reported to inhibit TNF-α-induced cell death, we studied whether NF-κB also assumes a protective role in TNF-α-induced cell death in prostate cancer cells. Materials and Methods: We used two human prostate cancer cell lines of DU145 and PC-3. We prepared two different NF-κB inhibitors, pyrrolidine dithiocarbamate (PDTC) and NF-κB decoy. NF-κB DNA binding activity was detected by electrophoretic mobility shift assay (EMSA). Cell survivals were measured by MTT assay. Induction of apoptosis was detected by nuclear staining and measured by fragmented DNA ELISA. Results: EMSA showed that NF-κB inhibitors continuously inhibited TNF-α-induced NF-κB activation. Cell growth was not inhibited by either TNF-α (50 ng./ml. or less) or NF-κB inhibitors. However, both PCA cells treated with TNF-α (20 ng./ml.) plus NF-κB inhibitors showed significant growth inhibition compared with controls (p <0.05). Nuclei of PCA cells appeared severely fragmented by this combination therapy. Furthermore, the levels of DNA fragmentation were significantly elevated in PCA cells treated with TNF-α (20 ng./ml.) plus NF-κB inhibitors compared with controls (p <0.05). Conclusions: NF-κB activation is suggested to produce the resistance of DU145 and PC-3 to TNF-α and that the combination of TNF-α and NF-κB inhibitors could be constituted an effective therapy to TNF-α-resistant human prostate cancer cells.

KW - Apoptosis

KW - NF-κB

KW - Prostate cancer

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=0033072728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033072728&partnerID=8YFLogxK

M3 - Article

C2 - 9915481

AN - SCOPUS:0033072728

VL - 161

SP - 674

EP - 679

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -